000 01323 a2200349 4500
005 20250518081815.0
264 0 _c20200831
008 202008s 0 0 eng d
022 _a1532-2130
024 7 _a10.1016/j.ejpn.2020.01.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLyons, Aisling
245 0 0 _aCatatonia as a feature of down syndrome: An under-recognised entity?
_h[electronic resource]
260 _bEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
_cMar 2020
300 _a187-190 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAnticonvulsants
_xtherapeutic use
650 0 4 _aCatatonia
_xdrug therapy
650 0 4 _aChild
650 0 4 _aDown Syndrome
_xcomplications
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLorazepam
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aRetrospective Studies
700 1 _aAllen, Nicholas M
700 1 _aFlanagan, Orla
700 1 _aCahalane, Deirdre
773 0 _tEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
_gvol. 25
_gp. 187-190
856 4 0 _uhttps://doi.org/10.1016/j.ejpn.2020.01.005
_zAvailable from publisher's website
999 _c30539946
_d30539946